2-hydroxymethyl-4-(4-methylphenyl)thiazole | 244152-82-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-hydroxymethyl-4-(4-methylphenyl)thiazole
• 英文别名: [4-(4-Methylphenyl)-1,3-thiazol-2-yl]methanol
• CAS: 244152-82-7
• 化学式: C₁₁H₁₁NOS
• 分子量: 205.28
• InChiKey: LCPBYVWZYHAONB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  61.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-hydroxymethyl-4-(4-methylphenyl)thiazole 在 氯化亚砜 、 sodium hydride 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 SP 00492
  参考文献：
  名称：

  [EN] METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1
  [FR] PROCÉDÉS ET COMPOSITIONS POUR L'INHIBITION DE CNKSR1

  摘要：

  公开号：

  WO2014093988A3
• 作为产物：
  描述：

  4-(4-甲基苯基)-2-噻唑羧酸乙酯 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 以78%的产率得到2-hydroxymethyl-4-(4-methylphenyl)thiazole
  参考文献：
  名称：

  [EN] METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1
  [FR] PROCÉDÉS ET COMPOSITIONS POUR L'INHIBITION DE CNKSR1

  摘要：

  公开号：

  WO2014093988A3

文献信息

• Carboxylic acid derivatives and drugs containing the same as the active ingredient
  申请人：ONO Pharmaceutical Co., Ltd.

  公开号：US06506757B1

  公开（公告）日：2003-01-14

  A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) (wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient. Because of having an effect of regulating PPAR, a compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or a remedy for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diseases or syndrome X.

  一种含有化学式(I)的羧酸衍生物的过氧化物酶增殖激活受体调节剂（其中所有符号均如规范中定义），其非毒性酸或其水合物作为活性成分。由于具有调节PPAR的作用，化学式(I)的化合物可用作降糖剂、降脂剂、与代谢紊乱（糖尿病、肥胖、X综合征、高胆固醇血症、高脂蛋白血症等）相关的疾病的预防和/或治疗、高脂血症、动脉粥样硬化、高血压、循环系统疾病、暴饮暴食、冠心病等，以及提高HDL胆固醇的药物、降低LDL胆固醇和/或VLDL胆固醇的药物，以及缓解疾病或X综合征风险因素的药物。
• Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
  申请人：Tajima Hisao

  公开号：US20050250824A1

  公开（公告）日：2005-11-10

  A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) (wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient. Because of having an effect of regulating PPAR, a compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or a remedy for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diseases or syndrome X.

  一种过氧化物酶体增殖物激活受体调节剂，包含化学式（I）的羧酸衍生物（其中所有符号如规范所定义），其非毒性酸或其水合物作为活性成分。由于具有调节PPAR的作用，化合物(I)可用作降血糖剂，降脂剂，预防和/或治疗代谢紊乱相关疾病（糖尿病，肥胖症，X综合症，高胆固醇血症，高脂蛋白血症等），高脂血症，动脉粥样硬化，高血压，循环系统疾病，暴饮暴食，冠心病等，一种HDL胆固醇升高剂，一种LDL胆固醇和/或VLDL胆固醇降低剂，以及一种缓解疾病或X综合症风险因素的药物。
• ANTIBACTERIAL AGENTS
  申请人：Brown David Ryall

  公开号：US20100173933A1

  公开（公告）日：2010-07-08

  Compounds of formula (I) have antibacterial activity: wherein R represents hydrogen or 1, 2 or 3 optional substituents; W is ═C(R 1 )— or ═N—; R 1 is hydrogen or an optional substituent and R 2 is hydrogen, methyl, or fluorine; or R 1 and R 2 taken together are —CH 2 —, —CH 2 CH 2 —, —O—, or, in either orientation, —O—CH 2 — or —OCH 2 CH 2 —; R 3 is a radical of formula -(Alk 1 ) m -(Z) p -(Alk 2 ) n -Q wherein m, p and n are independently 0 or 1, provided that at least one of m, p and n is 1, Z is —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, —N(CH 2 CH 3 )—, —C(═O)—, —O—(C═O)—, —C(═O)—O—, or an optionally substituted divalent monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted divalent bicyclic heterocyclic radical having 5 to 10 ring atoms; Alk 1 and Alk 2 are optionally substituted C 1 -C 6 alkylene, C 2 -C 6 alkenylene, or C 2 -C 6 alkynylene radicals, which may optionally terminate with or be interrupted by —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, or —N(CH 2 CH 3 )—; and Q is hydrogen, halogen, nitrile, or hydroxyl or an optionally substituted monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted bicyclic heterocyclic radical having 5 to 10 ring atoms.

  化学式为（I）的化合物具有抗菌活性：其中R代表氢或1、2或3个可选取代基；W是═C（R1）-或═N-；R1是氢或可选取代基，R2是氢、甲基或氟；或R1和R2一起取-CH2-、- -、-O-，或者，在任何方向上，取-O- -或-O -；R3是公式-(Alk1)m-(Z)p-(Alk2)n-Q的基团，其中m、p和n独立地为0或1，但至少有一个为1，Z是-O-、-S-、-S（O）-、-S（O2）-、-NH-、-N（CH3）-、-N（ ）-、-C（═O）-、-O-（C═O）-、-C（═O）-O-，或具有3至6个环原子的可选取代的单环碳环或杂环基团；或具有5至10个环原子的可选取代双环杂环基团；Alk1和Alk2是可选取代的C1-C6烷基、C2-C6烯基或C2-C6炔基基团，可以以-O-、-S-、-S（O）-、-S（O2）-、-NH-、-N（ ）-或-N（ ）-结尾或被中断；Q是氢、卤素、腈或羟基，或具有3至6个环原子的可选取代的单环碳环或杂环基团；或具有5至10个环原子的可选取代的双环杂环基团。
• CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1067109A1

  公开（公告）日：2001-01-10

  A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) (wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient. Because of having an effect of regulating PPAR, a compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or a remedy for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diseases or syndrome X.

  一种含有式 (I) 羧酸衍生物的过氧化物酶体增殖物激活受体调节剂 (其中所有符号如说明书中所定义）的羧酸衍生物、其无毒酸或其水合物作为活性成分。 由于具有调节 PPAR 的作用，式（I）化合物可用作降糖药、降脂药、预防和/或治疗与代谢紊乱（糖尿病、肥胖症、X 综合征、高胆固醇血症、高脂蛋白血症等）、高血脂症、动脉粥样硬化、高血压、循环系统疾病、暴饮暴食、冠心病等有关的疾病、提高高密度脂蛋白胆固醇的药物、降低低密度脂蛋白胆固醇和/或低密度脂蛋白胆固醇的药物，以及缓解疾病或 X 综合征风险因素的药物。
• METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1
  申请人：PHUSIS THERAPEUTICS, INC.

  公开号：US20150307482A1

  公开（公告）日：2015-10-29

  Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.